The chemotherapy combination that has become the standard of care for mesothelioma in many parts of the world appears to be making a modest but measurable difference for mesothelioma patients in The Netherlands.
Mesothelioma is caused almost exclusively by inhalation or ingestion of asbestos fibers and is notoriously resistant to most conventional treatments.
Within the last decade, chemotherapy with cisplatin-antifolate combinations has been shown to improve responses and prolong survival.